The Clinician Affective Reactivity Index: Validity and Reliability of a Clinician-Rated Assessment of Irritability.


Journal

Behavior therapy
ISSN: 1878-1888
Titre abrégé: Behav Ther
Pays: England
ID NLM: 1251640

Informations de publication

Date de publication:
03 2020
Historique:
received: 17 12 2018
revised: 22 09 2019
accepted: 11 10 2019
entrez: 7 3 2020
pubmed: 7 3 2020
medline: 9 9 2020
Statut: ppublish

Résumé

Irritability is impairing in youth and is the core feature of disruptive mood dysregulation disorder (DMDD). Currently, there are no established clinician-rated instruments to assess irritability in pediatric research and clinical settings. Clinician-rated measures ensure consistency of assessment across patients and are important specifically for treatment research. Here, we present data on the psychometric properties of the Clinician Affective Reactivity Index (CL-ARI), the first semistructured interview focused on pediatric irritability. The CL-ARI was administered to a transdiagnostic sample of 98 youth (M age = 12.66, SD = 2.47; 41% female). With respect to convergent validity, CL-ARI scores were (a) significantly higher for youth with DMDD than for any other diagnostic group, and (b) showed uniquely strong associations with other clinician-, parent-, and youth-report measures of irritability compared to measures of related constructs, such as anxiety. The three subscales of the CL-ARI (temper outbursts, irritable mood, impairment) showed excellent internal consistency. Test-retest reliability of the CL-ARI was adequate. These data support that irritability can be feasibly, validly, and reliably assessed by clinicians using the CL-ARI. A validated, gold-standard assessment of pediatric irritability is critical in advancing research and treatment efforts.

Identifiants

pubmed: 32138938
pii: S0005-7894(19)30127-3
doi: 10.1016/j.beth.2019.10.005
pmc: PMC7060970
mid: NIHMS1545691
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT00006177', 'NCT00025935', 'NCT00018057', 'NCT02531893']

Types de publication

Journal Article Research Support, N.I.H., Intramural Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

283-293

Subventions

Organisme : Intramural NIH HHS
ID : ZIA MH002781
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA MH002786-17
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA MH002786
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA MH002778
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA MH002781-17
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA MH002778-19
Pays : United States

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Conflict of Interest Statement The authors declare there are no conflicts of interest.

Références

Am J Psychiatry. 2007 Aug;164(8):1238-41
pubmed: 17671287
J Child Adolesc Psychopharmacol. 2016 Mar;26(2):147-53
pubmed: 26844707
J Am Acad Child Psychiatry. 1984 Mar;23(2):191-7
pubmed: 6715741
Eur Child Adolesc Psychiatry. 2011 Feb;20(2):61-6
pubmed: 21298306
J Child Adolesc Psychopharmacol. 2016 Mar;26(2):94-100
pubmed: 26491995
J Child Adolesc Psychopharmacol. 2016 Mar;26(2):138-46
pubmed: 26859630
J Affect Disord. 2017 Jun;215:281-287
pubmed: 28363151
J Am Acad Child Adolesc Psychiatry. 2016 Jul;55(7):556-70
pubmed: 27343883
Am J Psychiatry. 2017 Jun 1;174(6):520-532
pubmed: 28103715
J Child Adolesc Psychopharmacol. 2016 Mar;26(2):101-6
pubmed: 26745442
N Engl J Med. 2001 Apr 26;344(17):1279-85
pubmed: 11323729
J Consult Clin Psychol. 1984 Dec;52(6):955-67
pubmed: 6520288
Depress Anxiety. 2014 Jul;31(7):566-73
pubmed: 23818321
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Am J Psychiatry. 2013 Feb;170(2):173-9
pubmed: 23377638
Am J Psychiatry. 2009 Sep;166(9):1048-54
pubmed: 19570932
J Child Adolesc Psychopharmacol. 2016 Feb;26(1):49-57
pubmed: 26745832
J Am Acad Child Adolesc Psychiatry. 2013 Aug;52(8):831-40
pubmed: 23880493
J Child Psychol Psychiatry. 2012 Nov;53(11):1109-17
pubmed: 22574736
J Clin Psychiatry. 2012 Oct;73(10):1342-50
pubmed: 23140653
Annu Rev Clin Psychol. 2017 May 8;13:317-341
pubmed: 28482689
J Am Acad Child Adolesc Psychiatry. 2002 Sep;41(9):1061-9
pubmed: 12218427
Trends Cogn Sci. 2017 Apr;21(4):277-289
pubmed: 28274677
J Am Acad Child Adolesc Psychiatry. 1994 Oct;33(8):1158-64
pubmed: 7982866
J Child Adolesc Psychopharmacol. 2016 Mar;26(2):123-30
pubmed: 26745325
Psychol Bull. 1979 Mar;86(2):420-8
pubmed: 18839484
Am J Psychiatry. 2014 Sep;171(9):918-24
pubmed: 25178749
J Child Psychol Psychiatry. 2013 May;54(5):501-2
pubmed: 23662786
J Am Acad Child Adolesc Psychiatry. 1997 Apr;36(4):545-53
pubmed: 9100430
J Atten Disord. 2013 Aug;17(6):527-41
pubmed: 22373865
Child Psychiatry Hum Dev. 2019 Jun;50(3):473-482
pubmed: 30460424
Am J Psychiatry. 2016 Jul 1;173(7):722-30
pubmed: 26892942
J Child Adolesc Psychopharmacol. 2009 Feb;19(1):61-73
pubmed: 19232024
J Child Adolesc Psychopharmacol. 2016 Mar;26(2):107-13
pubmed: 26771536
Bipolar Disord. 2012 Aug;14(5):488-96
pubmed: 22713098
Acta Paedopsychiatr. 1981 Feb;46(5-6):305-15
pubmed: 7025571
Arch Gen Psychiatry. 1983 Nov;40(11):1228-31
pubmed: 6639293
J Am Acad Child Adolesc Psychiatry. 2020 Mar;59(3):350-361
pubmed: 31128268
J Abnorm Child Psychol. 2015 Nov;43(8):1543-1549
pubmed: 26004122
J Am Acad Child Adolesc Psychiatry. 2016 Jan;55(1):54-61
pubmed: 26703910
Psychol Assess. 2019 Feb;31(2):236-247
pubmed: 30359050
Biol Psychiatry. 2006 Nov 1;60(9):991-7
pubmed: 17056393
Curr Treat Options Psychiatry. 2018 Mar;5(1):129-140
pubmed: 30319935
Arch Gen Psychiatry. 1987 Sep;44(9):821-4
pubmed: 3632256
Trials. 2018 Nov 14;19(1):626
pubmed: 30428909

Auteurs

Simone P Haller (SP)

Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health. Electronic address: simone.haller@nih.gov.

Katharina Kircanski (K)

Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health.

Argyris Stringaris (A)

Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health.

Michal Clayton (M)

Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health.

Hong Bui (H)

Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health.

Courtney Agorsor (C)

Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health.

Sofia I Cardenas (SI)

Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health.

Kenneth E Towbin (KE)

Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health.

Daniel S Pine (DS)

Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health.

Ellen Leibenluft (E)

Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health.

Melissa A Brotman (MA)

Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH